FFCP PHASE1:Mm9::chr17:34938699..34938704,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=55|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:34938699..34938704,-|id=chr17:34938699..34938704,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!3.96e-56!7;UBERON:0006858!3.96e-56!7;UBERON:0002342!2.86e-39!10;UBERON:0005062!2.86e-39!10;UBERON:0003064!5.20e-28!14;UBERON:0005157!2.12e-14!27;UBERON:0000305!3.04e-09!1;UBERON:0005256!4.16e-08!47;UBERON:0005172!9.29e-08!49;UBERON:0005173!9.29e-08!49;UBERON:0002417!9.29e-08!49;UBERON:0000916!9.29e-08!49;UBERON:0002346!9.27e-07!71;UBERON:0003075!9.27e-07!71;UBERON:0007284!9.27e-07!71|ontology_enrichment_uberon_v019_2=UBERON:0002369,3.78e-62,7;UBERON:0006858,3.78e-62,7;UBERON:0003064,1.51e-31,14;UBERON:0005256,2.64e-10,45;UBERON:0005172,1.64e-09,49;UBERON:0005173,1.64e-09,49;UBERON:0002417,1.64e-09,49;UBERON:0000916,1.64e-09,49;UBERON:0002368,7.20e-08,60;UBERON:0003104,9.51e-08,61;UBERON:0009142,9.51e-08,61;UBERON:0002530,2.65e-07,65;UBERON:0009569,3.36e-07,66|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.890652834388949,0.173485326766136,2.13125834818499,1.61430848079241,2.26083960828934,2.93971767839262,1.25666591329675,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210441855886474,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191288332068843,0,0|short_description=p@chr17:34938699..34938704,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=55 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:34938699..34938704,- | |||
|description=CAGE_peak_at_chr17:34938699..34938704,- | |||
|id=chr17:34938699..34938704,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!3.96e-56!7;UBERON:0006858!3.96e-56!7;UBERON:0002342!2.86e-39!10;UBERON:0005062!2.86e-39!10;UBERON:0003064!5.20e-28!14;UBERON:0005157!2.12e-14!27;UBERON:0000305!3.04e-09!1;UBERON:0005256!4.16e-08!47;UBERON:0005172!9.29e-08!49;UBERON:0005173!9.29e-08!49;UBERON:0002417!9.29e-08!49;UBERON:0000916!9.29e-08!49;UBERON:0002346!9.27e-07!71;UBERON:0003075!9.27e-07!71;UBERON:0007284!9.27e-07!71 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,3.78e-62,7;UBERON:0006858,3.78e-62,7;UBERON:0003064,1.51e-31,14;UBERON:0005256,2.64e-10,45;UBERON:0005172,1.64e-09,49;UBERON:0005173,1.64e-09,49;UBERON:0002417,1.64e-09,49;UBERON:0000916,1.64e-09,49;UBERON:0002368,7.20e-08,60;UBERON:0003104,9.51e-08,61;UBERON:0009142,9.51e-08,61;UBERON:0002530,2.65e-07,65;UBERON:0009569,3.36e-07,66 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.890652834388949,0.173485326766136,2.13125834818499,1.61430848079241,2.26083960828934,2.93971767839262,1.25666591329675,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210441855886474,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191288332068843,0,0 | |||
|short_description=p@chr17:34938699..34938704,- | |||
}} |
Latest revision as of 17:56, 4 August 2015
Short description: | p@chr17:34938699..34938704, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:34938699..34938704, - |
Coexpression cluster: | MCL_coexpression_mm9:55 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 3.78e-62 | 7 |
adrenal/interrenal gland | 3.78e-62 | 7 |
intermediate mesoderm | 1.51e-31 | 14 |
trunk mesenchyme | 2.64e-10 | 45 |
abdomen element | 1.64e-09 | 49 |
abdominal segment element | 1.64e-09 | 49 |
abdominal segment of trunk | 1.64e-09 | 49 |
abdomen | 1.64e-09 | 49 |
endocrine gland | 7.20e-08 | 60 |
mesenchyme | 9.51e-08 | 61 |
entire embryonic mesenchyme | 9.51e-08 | 61 |
gland | 2.65e-07 | 65 |
subdivision of trunk | 3.36e-07 | 66 |